Autophagy in malignant transformation and cancer progression.

Galluzzi, Lorenzo; Pietrocola, Federico; Bravo-San Pedro, José Manuel; Amaravadi, Ravi K; Baehrecke, Eric H; Cecconi, Francesco; Codogno, Patrice; Debnath, Jayanta; Gewirtz, David A; Karantza, Vassiliki; Kimmelman, Alec; Kumar, Sharad; Levine, Beth; Maiuri, Maria Chiara; Martin, Seamus J; Penninger, Josef; Piacentini, Mauro; Rubinsztein, David C; Simon, Hans-Uwe; Simonsen, Anne; ... (2015). Autophagy in malignant transformation and cancer progression. EMBO journal, 34(7), pp. 856-880. Nature Publishing Group 10.15252/embj.201490784

[img] Text
Autophagy in malignant transformation and cancer progression.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (9MB) | Request a copy

Autophagy plays a key role in the maintenance of cellular homeostasis. In healthy cells, such a homeostatic activity constitutes a robust barrier against malignant transformation. Accordingly, many oncoproteins inhibit, and several oncosuppressor proteins promote, autophagy. Moreover, autophagy is required for optimal anticancer immunosurveillance. In neoplastic cells, however, autophagic responses constitute a means to cope with intracellular and environmental stress, thus favoring tumor progression. This implies that at least in some cases, oncogenesis proceeds along with a temporary inhibition of autophagy or a gain of molecular functions that antagonize its oncosuppressive activity. Here, we discuss the differential impact of autophagy on distinct phases of tumorigenesis and the implications of this concept for the use of autophagy modulators in cancer therapy.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology

UniBE Contributor:

Simon, Hans-Uwe

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0261-4189

Publisher:

Nature Publishing Group

Language:

English

Submitter:

Debora Scherrer

Date Deposited:

23 Jul 2015 16:09

Last Modified:

26 May 2016 10:13

Publisher DOI:

10.15252/embj.201490784

PubMed ID:

25712477

Uncontrolled Keywords:

Beclin 1; KRAS; adaptive stress responses; inflammation; mitophagy

BORIS DOI:

10.7892/boris.70458

URI:

https://boris.unibe.ch/id/eprint/70458

Actions (login required)

Edit item Edit item
Provide Feedback